Key Factor Supporting Biopsy Needle Market Development in 2025: Increasing Demand For Minimally Invasive Procedures Fueling The Growth Of The Market Due To Faster Recovery And Reduced Patient Trauma

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Biopsy Needle Market Size By 2025?
In the past few years, there has been a substantial growth in the biopsy needle market size. The market which was valued at $1.30 billion in 2024 is expected to rise to $1.41 billion in 2025, representing a compound annual growth rate (CAGR) of 8.3%. The growth observed in the historical period is believed to be due to factors such as the growing popularity of minimally invasive procedures, amplified awareness about preemptive diagnosis, an increase in the elderly demographic, greater adoption of image-guided biopsy methods, and an escalating requirement for prompt and precise diagnoses.

How Big Is the Biopsy Needle Market Size Expected to Grow by 2029?
The market size of the biopsy needle is anticipated to witness a significant rise in the coming years, reaching $1.91 billion by 2029, at a Compound Annual Growth Rate (CAGR) of 7.9%. Several factors contribute to this growth in the forecast period, such as the increasing demand for advanced diagnostic instruments, the amplifying number of screening programs, the growth of the private healthcare sector in budding economies, the rise in the availability of biopsy procedures, as well as the heightened focus on patient safety. Key trends expected within the forecast period are improvements in needle design and precision, advancements in imaging technologies for biopsy guidance, the incorporation of robot-assisted biopsy systems, real-time data monitoring during procedures, and introduction of novel disposable biopsy needles for infection control.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biopsy-needle-global-market-report

Which Key Market Drivers Powering Biopsy Needle Market Expansion and Growth?
The biopsy needle market is projected to thrive due to the rising demand for minimally invasive procedures. Such procedures encompass medical interventions carried out through tiny openings or cuts, resulting in decreased patient trauma and a shrinking recovery timeline. Minimally invasive surgeries have seen an upsurge in demand due to their advantages like reduced recovery period, lesser complication risks, lesser pain, and smaller scars, thus rendering them as desirable alternatives for patients seeking faster and safer treatment regimens. Biopsy needles play an instrumental role in minimally invasive procedures by facilitating accurate tissue sampling, thereby minimizing the requirement for surgical intervention. They contribute to faster diagnoses and recovery periods, enhancing patient comfort and the efficacy of the procedure. For example, the American Society of Plastic Surgeons, a non-profit organization based in the US, reported in November 2024 that the total count of cosmetic minimally invasive procedures hit 25,442,640 in 2023, registering a 7% rise from 23,672,269 in 2022. Hence, the escalating demand for minimally invasive procedures is bolstering the growth of the biopsy needle market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27224&type=smp

What Long-Term Trends Will Define the Future of the Biopsy Needle Market?
Primary businesses in the biopsy needle market, such as Argon Medical Devices Inc., are turning their focus towards the creation of technologically advanced instruments like semi-automatic core biopsy tools. These devices, designed to improve the accuracy and simplicity of tissue sampling in minimally invasive procedures, utilize a spring-loaded mechanism to swiftly and precisely gather tissue samples with minimal human effort during a biopsy. An example of this advancement was seen in May 2023, when Argon Medical Devices Inc. introduced the SuperCore Advantage, a semi-automatic biopsy implement. This single-use core biopsy needle consistently delivers high-quality tissue samples, crucial in providing accurate diagnoses. It touts an ergonomic design, clean specimen retrieval due to its sharp cutting edge, and an adjustable throw length to cater to varying lesion depths. Furthermore, this device increases biopsy accuracy and lessens patient discomfort, thereby offering enhanced diagnostic choices for patients.

What Are the Emerging Segments in the Biopsy Needle Market?
The biopsy needle market covered in this report is segmented

1) By Type: Disposable, Non-Disposable
2) By Product: Needle Based Biopsy Guns, Vacuum-Assisted Biopsy Devices, Fine Needle Aspiration Biopsy Devices, Core Needle Biopsy Devices
3) By Procedure: Image-Guided Procedures, Non-Image-Guided Procedures
4) By Application: Cancer Or Tumor, Breast, Lung, Prostate, Colon, Stomach, Liver, , Cervix Uteri, Other Applications
5) By End-User: Hospitals And Surgical Centers, Diagnostic Clinics And Pathology Laboratories, Ambulatory Care Centers, Research And Academic Institutes

Subsegments:
1) By Disposable: Coaxial Biopsy Needles, Chiba Needles, Jamshidi Needles
2) By Non-Disposable: Reusable Tru-Cut Biopsy Needles, Reusable Menghini Needles, Reusable Francine Needles

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27224&type=smp

Who Are the Global Leaders in the Biopsy Needle Market?
Major companies operating in the biopsy needle market are Cardinal Health Inc., Medtronic plc, Becton, inson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Hologic Inc., Cook Medical, Halma plc, Merit Medical Systems Inc., ConMed Corporation, Devicor Medical Products Inc., Shandong Weigao Group Medical Polymer Company Limited, Remington Medical Inc., Advin Health Care, Nikotech Healthcare Pvt. Ltd., Argon Medical Devices Inc., Geotek Medical Products Co. Ltd., Biomedical Srl, Hakko Co. Ltd., INRAD Inc.

Which are the Top Profitable Regional Markets for the Biopsy Needle Industry?
North America was the largest region in the biopsy needle market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopsy needle market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27224

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.